- Home
- CHCT vs ABEO Comparison
CHCT vs ABEO Comparison
Compare CHCT & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHCT | ABEO |
|---|---|---|
| Founded | 2014 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 410.0M | 399.5M |
| IPO Year | 2015 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CHCT | ABEO |
|---|---|---|
| Price | $14.09 | $5.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $17.50 | ★ $18.88 |
| AVG Volume (30 Days) | 264.5K | ★ 1.3M |
| Earning Date | 10-27-2026 | 11-11-2026 |
| Dividend Yield | ★ 13.54% | N/A |
| EPS Growth | 134.78 | ★ 165.16 |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $121,195,000.00 | $2,998,000.00 |
| Revenue This Year | $4.24 | $804.33 |
| Revenue Next Year | $5.43 | $119.68 |
| P/E Ratio | $119.17 | ★ N/A |
| Revenue Growth | 4.67 | ★ 258.18 |
| 52 Week Low | $13.23 | $4.00 |
| 52 Week High | $19.17 | $7.65 |
Technical Indicators
Market Signals| Indicator | CHCT | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 34.28 | 35.55 |
| Support Level | $14.11 | $4.94 |
| Resistance Level | $15.22 | $5.46 |
| Average True Range (ATR) | 0.24 | 0.21 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 6.25 | 11.39 |
Price Performance
Historical ComparisonAbout CHCT Community Healthcare Trust Incorporated
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.